Attached files
file | filename |
---|---|
EX-31 - EX-31 - MYRIAD GENETICS INC | mygn-ex31_11.htm |
EX-23.1 - EX-23.1 - MYRIAD GENETICS INC | mygn-ex231_6.htm |
EX-21.1 - EX-21.1 - MYRIAD GENETICS INC | mygn-ex211_8.htm |
EX-10.11 - EX-10.11 - MYRIAD GENETICS INC | mygn-ex1011_355.htm |
10-K - 10-K - MYRIAD GENETICS INC | mygn-10k_20200630.htm |
Exhibit 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 10-K for the year ended June 30, 2020 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 13, 2020 |
|
|
|
|
|
/s/ R. Bryan Riggsbee |
|
|
|
|
|
R. Bryan Riggsbee |
|
|
Interim President and Chief Executive Officer, Chief Financial Officer |
|
|
|
|
|